tirzepatide pregnancy breastfeeding guidance What are the recommended guidelines for initiating in adult patients for weight loss, including BMI eligibility, contraindications (e.g., medullary thyroid carcinoma, multiple endocrine neoplasia type 2, active pancreatitis, or ๐จ New Research Alert: Tirzepatide
Description
Locked-in commitments during regulatory uncertainty Be cautious about providers requiring long-term commitments, especially in the current regulatory environment
It is administered as a once-weekly subcutaneous injection, with sites ranging from the abdomen to the upper arm

Before starting any medication, it is essential to understand who the medication is designed for and the health conditions it treats

Those who stop GLP-1 therapy may also gain more weight during pregnancy compared to those who were never on treatment

Zero human studies

Its important to remember that not everyone needs the higher dosage of Mounjaro, which should only be increased after consulting with your healthcare provider
